Dario Pressimone Joins Edible Garden as Vice President of Digital and E-Commerce
BELVIDERE, NJ, Nov. 18, 2024 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), […]
Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Actively Exploring Partnership for Alzheimer’s DevelopmentSupplementary Financing Concluded in Q4 ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) — Vaccinex, Inc. […]
CSW Industrials Updates Share Repurchase Program
DALLAS, Nov. 18, 2024 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (Nasdaq: CSWI) today announced its Board of Directors authorized a […]
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
Ms. Nassif brings an extensive track record of successfully developing commercial strategies for multiple FDA-approved drugs Appointment initiates Cassava’s commercial […]
Nuvini (Nasdaq: NVNI) Announces Aaron Ross as Board Adviser
NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) — Nvni Group Limited (Nasdaq: NVNI) (“Nuvini”), the leading serial acquirer of private […]
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
FLORHAM PARK, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, […]
Complete Solar’s Blue Raven Signs Installation Agreement with Sunder Energy
LEHI, Utah, Nov. 18, 2024 (GLOBE NEWSWIRE) — Blue Raven Solar (“BRS”) a division of Complete Solar Holdings, Inc. (“Complete […]
Nano Dimension Reminds Shareholders that Time Is Running Out to Protect Their Investment – Vote FOR Nano’s Proposals
Deadline is Fast Approaching on Sunday, December 1st, 2024, at 11:59 p.m. ET Shareholders Should Call Their Brokers Today to Ensure […]
Aclaris Therapeutics Announces $80 Million Private Placement
WAYNE, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the “Company” or “Aclaris”), a clinical-stage biopharmaceutical […]
Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline
– Enhances Aclaris’ pipeline with complementary biologics portfolio –– Expands leadership team with addition of seasoned biotech executives –– Management […]
